Literature DB >> 10609594

Needle-exchange attendance and health care utilization promote entry into detoxification.

S A Strathdee1, D D Celentano, N Shah, C Lyles, V A Stambolis, G Macalino, K Nelson, D Vlahov.   

Abstract

This study was undertaken to identify factors associated with entry into detoxification among injection drug users (IDUs), and to assess the role of needle-exchange programs (NEPs) as a bridge to treatment. IDUs undergoing semiannual human immunodeficiency virus (HIV) tests and interviews were studied prospectively between 1994 and 1998, during which time an NEP was introduced in Baltimore. Logistic regression was used to identify independent predictors of entry into detoxification, stratifying by HIV serostatus. Of 1,490 IDUs, similar proportions of HIV-infected and uninfected IDUs entered detoxification (25% vs. 23%, respectively). After accounting for recent drug use, hospital admission was associated with four-fold increased odds of entering detoxification for HIV-seronegative subjects. Among HIV-infected subjects, hospital admission, outpatient medical care, and having health insurance independently increased the odds of entering detoxification. After accounting for these and other variables, needle-exchange attendance also was associated independently with entering detoxification for both HIV-infected (adjusted odds ratio [AOR] = 3.2) and uninfected IDUs (AOR = 1.4). However, among HIV-infected subjects, the increased odds of detoxification associated with needle exchange diminished significantly over time, concomitant with statewide reductions in detoxification admissions. These findings indicate that health care providers and NEPs represent an important bridge to drug abuse treatment for HIV-infected and uninfected IDUs. Creating and sustaining these linkages may facilitate entry into drug abuse treatment and serve the important public health goal of increasing the number of drug users in treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10609594      PMCID: PMC3456698          DOI: 10.1007/BF02351502

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  18 in total

1.  The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Authors:  D Vlahov; J C Anthony; A Munoz; J Margolick; K E Nelson; D D Celentano; L Solomon; B F Polk
Journal:  NIDA Res Monogr       Date:  1991

2.  Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population.

Authors:  J De Irala; C Bigelow; J McCusker; R Hindin; L Zheng
Journal:  Am J Epidemiol       Date:  1996-04-01       Impact factor: 4.897

3.  Can syringe exchange serve as a conduit to substance abuse treatment?

Authors:  R Heimer
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

Review 4.  Can HIV epidemics among injection drug users be prevented?

Authors:  S A Strathdee; E J van Ameijden; F Mesquita; A Wodak; S Rana; D Vlahov
Journal:  AIDS       Date:  1998       Impact factor: 4.177

5.  Syringe use and reuse: effects of syringe exchange programs in four cities.

Authors:  R Heimer; K Khoshnood; D Bigg; J Guydish; B Junge
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

6.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.

Authors:  D Vlahov; B Junge; R Brookmeyer; S Cohn; E Riley; H Armenian; P Beilenson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-15

7.  Effectiveness of needle-exchange programmes for prevention of HIV infection.

Authors:  S F Hurley; D J Jolley; J M Kaldor
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

8.  Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.

Authors:  C G Schütz; E Rapiti; D Vlahov; J C Anthony
Journal:  Drug Alcohol Depend       Date:  1994-10       Impact factor: 4.492

9.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users.

Authors:  C A Latkin; D Vlahov; J C Anthony
Journal:  Addiction       Date:  1993-04       Impact factor: 6.526

10.  Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction.

Authors:  J McCusker; C Bigelow; R Luippold; M Zorn; B F Lewis
Journal:  Am J Drug Alcohol Abuse       Date:  1995-02       Impact factor: 3.829

View more
  45 in total

1.  Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998.

Authors:  H Brahmbhatt; D Bigg; S A Strathdee
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

2.  Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.

Authors:  Traci C Green; Ricky N Bluthenthal; Merrill Singer; Leo Beletsky; Lauretta E Grau; Patricia Marshall; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

3.  Health care utilization among drug-using and non-drug-using women.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

4.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

5.  Placing the dynamics of syringe exchange programs in the United States.

Authors:  Barbara Tempalski
Journal:  Health Place       Date:  2006-06-21       Impact factor: 4.078

6.  Reducing barriers to hepatitis C treatment among drug users: an integrated hepatitis C peer education and support program.

Authors:  Robert J Roose; Lauren Cockerham-Colas; Irene Soloway; Abigail Batchelder; Alain H Litwin
Journal:  J Health Care Poor Underserved       Date:  2014-05

7.  Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Rebecca B Hershow; Michelle Gonzalez; Elizabeth Costenbader; William Zule; Carol Golin; Lauren Brinkley-Rubinstein
Journal:  AIDS Educ Prev       Date:  2019-08

8.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

9.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

Review 10.  Recent advances in the treatment of opiate addiction.

Authors:  Paul J Fudala; George W Woody
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.